SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-140003
Filing Date
2024-05-16
Accepted
2024-05-16 07:31:06
Documents
14
Period of Report
2024-05-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d834548d8k.htm   iXBRL 8-K 39602
  Complete submission text file 0001193125-24-140003.txt   204748

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA xoma-20240515.xsd EX-101.SCH 3869
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20240515_def.xml EX-101.DEF 14110
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20240515_lab.xml EX-101.LAB 23494
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20240515_pre.xml EX-101.PRE 15143
18 EXTRACTED XBRL INSTANCE DOCUMENT d834548d8k_htm.xml XML 7095
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 24953569
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)